Article By:
Benzinga
Sunday, August 9, 2020 2:22 PM EDT
Biotech stocks advanced in the week ended August 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus treatment/vaccine news flow supported the move to the upside.